Clinical Trial Update: Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the effect of eplerenone on heart function in women receiving anthracycline chemotherapy for breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inspra (Eplerenone) (Eplerenone)

Snippet

Sponsor: University of British Columbia | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: TERMINATED